Literature DB >> 26361259

Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies.

S A Morshed1, T F Davies1.   

Abstract

The immunologic processes involved in Graves' disease (GD) have one unique characteristic--the autoantibodies to the TSH receptor (TSHR)--which have both linear and conformational epitopes. Three types of TSHR antibodies (stimulating, blocking, and cleavage) with different functional capabilities have been described in GD patients, which induce different signaling effects varying from thyroid cell proliferation to thyroid cell death. The establishment of animal models of GD by TSHR antibody transfer or by immunization with TSHR antigen has confirmed its pathogenic role and, therefore, GD is the result of a breakdown in TSHR tolerance. Here we review some of the characteristics of TSHR antibodies with a special emphasis on new developments in our understanding of what were previously called "neutral" antibodies and which we now characterize as autoantibodies to the "cleavage" region of the TSHR ectodomain. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26361259      PMCID: PMC5047290          DOI: 10.1055/s-0035-1559633

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  47 in total

Review 1.  Regulation of nuclear factor kappaB activation by G-protein-coupled receptors.

Authors:  R D Ye
Journal:  J Leukoc Biol       Date:  2001-12       Impact factor: 4.962

2.  Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema.

Authors:  C Kamath; S Young; K Kabelis; J Sanders; M A Adlan; J Furmaniak; B Rees Smith; L D Premawardhana
Journal:  Clin Endocrinol (Oxf)       Date:  2012-09       Impact factor: 3.478

3.  Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample.

Authors:  Michele Evans; Jane Sanders; Tetsuya Tagami; Paul Sanders; Stuart Young; Emma Roberts; Jane Wilmot; Xiaoling Hu; Katarzyna Kabelis; Jill Clark; Sabrina Holl; Tonya Richards; Alastair Collyer; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Clin Endocrinol (Oxf)       Date:  2010-06-09       Impact factor: 3.478

4.  Graves' disease TSHR-stimulating antibodies (TSAbs) induce the activation of immature thymocytes: a clue to the riddle of TSAbs generation?

Authors:  Mireia Giménez-Barcons; Roger Colobran; Ana Gómez-Pau; Ana Marín-Sánchez; Anna Casteràs; Gabriel Obiols; Raúl Abella; Joaquín Fernández-Doblas; Massimo Tonacchera; Ana Lucas-Martín; Ricardo Pujol-Borrell
Journal:  J Immunol       Date:  2015-03-23       Impact factor: 5.422

5.  Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.

Authors:  Paul Sanders; Stuart Young; Jane Sanders; Katarzyna Kabelis; Stuart Baker; Andrew Sullivan; Michele Evans; Jill Clark; Jane Wilmot; Xiaoling Hu; Emma Roberts; Michael Powell; Ricardo Núñez Miguel; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  J Mol Endocrinol       Date:  2011-02-15       Impact factor: 5.098

6.  Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells.

Authors:  Miguel A Zaballos; Bibian Garcia; Pilar Santisteban
Journal:  Mol Endocrinol       Date:  2008-01-17

7.  Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.

Authors:  J Sanders; J Jeffreys; H Depraetere; M Evans; T Richards; A Kiddie; K Brereton; L D K E Premawardhana; D Y Chirgadze; R Núñez Miguel; T L Blundell; J Furmaniak; B Rees Smith
Journal:  Thyroid       Date:  2004-08       Impact factor: 6.568

8.  TSH induces metallothionein 1 in thyrocytes via Gq/11- and PKC-dependent signaling.

Authors:  Christer M Bäck; Stefanie Stohr; Eva A M Schäfer; Heike Biebermann; Ingrid Boekhoff; Andreas Breit; Thomas Gudermann; Thomas R H Büch
Journal:  J Mol Endocrinol       Date:  2013-06-04       Impact factor: 5.098

9.  Graves' IgG recognizes linear epitopes in the human thyrotropin receptor.

Authors:  E V Nagy; H B Burch; K Mahoney; Y G Lukes; J C Morris; K D Burman
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

10.  Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease.

Authors:  Tina Muehlberg; Jacqueline A Gilbert; Prakash V Rao; Alan M McGregor; J Paul Banga
Journal:  Endocrinology       Date:  2004-02-05       Impact factor: 4.736

View more
  40 in total

Review 1.  Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markers.

Authors:  Christoph Langenstein; Diana Schork; Klaus Badenhoop; Eva Herrmann
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

2.  Hyperthyroidism After Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study.

Authors:  Peter D Inskip; Lene H S Veiga; Alina V Brenner; Alice J Sigurdson; Evgenia Ostroumova; Eric J Chow; Marilyn Stovall; Susan A Smith; Wendy Leisenring; Leslie L Robison; Gregory T Armstrong; Charles A Sklar; Jay H Lubin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-12       Impact factor: 7.038

Review 3.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

4.  Biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Sci Signal       Date:  2018-01-23       Impact factor: 8.192

Review 5.  Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review.

Authors:  Renato Tozzoli; Danilo Villalta; Nicola Bizzaro
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

6.  Cleavage Region Thyrotropin Receptor Antibodies Influence Thyroid Cell Survival In Vivo.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Thyroid       Date:  2019-06-04       Impact factor: 6.568

7.  The clinical phenotype of Graves' disease occurring as an isolated condition or in association with other autoimmune diseases.

Authors:  M Rotondi; C Virili; S Pinto; F Coperchini; L Croce; N Brusca; M Centanni; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-08-12       Impact factor: 4.256

8.  Teprotumumab for Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; George J Kahaly; Daniel G Ezra; James C Fleming; Roger A Dailey; Rosa A Tang; Gerald J Harris; Alessandro Antonelli; Mario Salvi; Robert A Goldberg; James W Gigantelli; Steven M Couch; Erin M Shriver; Brent R Hayek; Eric M Hink; Richard M Woodward; Kathleen Gabriel; Guido Magni; Raymond S Douglas
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

9.  Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10.

Authors:  Theresa Porst; Jörg Johannes; Hans Gluschke; Richard Köhler; Sebastian Mehl; Peter Kühnen; Kostja Renko; Waldemar B Minich; Susanna Wiegand; Lutz Schomburg
Journal:  Biomedicines       Date:  2021-04-30

10.  PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves' ophthalmopathy through SREBP2/HMGCR pathway.

Authors:  Mira Park; Jae Yeon Kim; Jun Mo Kang; Hey Jin Lee; Jasvinder Paul Banga; Gi Jin Kim; Helen Lew
Journal:  Stem Cell Res Ther       Date:  2021-05-29       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.